Amir Nashat

Insider Reports History

Location
San Diego, CA
Signature
By: /s/ Lauren Crockett, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Amir Nashat:

Company Role Class Num Shares Value Price $ Report Date Ownership
Scholar Rock Holding Corp Director Common Stock 38,639 $608,302 $15.74 09 May 2024 Direct
Camp4 Therapeutics Corp Director, 10%+ Owner Common Stock 197,661 $302,421 $1.53 11 Sep 2025 Indirect
Morphic Holding, Inc. Director Common Stock 0 $0 $55.79 16 Aug 2024 By Polaris Entrepreneurs' Fund VII, L.P.
Morphic Holding, Inc. Director Common Stock 0 $0 $55.79 16 Aug 2024 By Polaris Partners VII, L.P.
Morphic Holding, Inc. Director Common Stock 0 $0 $55.79 16 Aug 2024 Direct
Scholar Rock Holding Corp Director Common Stock 0 $0 $15.74 09 May 2024 Indirect
Scholar Rock Holding Corp Director Stock Option (Right to Buy) 36,000 21 Jun 2023 Direct
Syros Pharmaceuticals, Inc. Director Stock Option (right to buy) 17,500 01 Jun 2022 Direct
Metacrine, Inc. Director, 10%+ Owner Stock Option (right to buy) 16,500 18 May 2022 Direct
Camp4 Therapeutics Corp Director, 10%+ Owner Stock Option (Right to Buy) 9,000 25 Jun 2025 Direct
Camp4 Therapeutics Corp Director, 10%+ Owner Series A Prime Preferred Stock 0 15 Oct 2024 Indirect
Camp4 Therapeutics Corp Director, 10%+ Owner Series B Preferred Stock 0 15 Oct 2024 Indirect
Morphic Holding, Inc. Director Stock Option (Right to Buy) 0 16 Aug 2024 Direct

Insider Reports Filed by Amir Nashat

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CAMP Camp4 Therapeutics Corp 11 Sep 2025 2 +$1,999,999 4 Director, 10%+ Owner 11 Sep 2025, 16:48
CAMP Camp4 Therapeutics Corp 25 Jun 2025 1 $0 4 Director, 10%+ Owner 27 Jun 2025, 16:02
CAMP Camp4 Therapeutics Corp 15 Oct 2024 9 +$9,999,990 4 Director, 10%+ Owner 15 Oct 2024, 17:49
CAMP Camp4 Therapeutics Corp 10 Oct 2024 0 $0 3 Director, 10%+ Owner 10 Oct 2024, 21:05
/report/000141588924021767-nashat-amir-2024-08-16 Morphic Holding, Inc. 16 Aug 2024 9 $0 4 Director 20 Aug 2024, 19:11
/report/000141588924015668-nashat-amir-2024-06-04 Morphic Holding, Inc. 04 Jun 2024 1 $0 4 Director 05 Jun 2024, 19:12
SRRK Scholar Rock Holding Corp 09 May 2024 9 $0 4 Director 13 May 2024, 16:17
SRRK Scholar Rock Holding Corp 27 Dec 2023 1 $0 4 Director 29 Dec 2023, 16:40
SRRK Scholar Rock Holding Corp 13 Dec 2023 9 $0 4 Director 15 Dec 2023, 16:26
SRRK Scholar Rock Holding Corp 20 Nov 2023 9 $0 4 Director 22 Nov 2023, 16:30
/report/000089924323016770-nashat-amir-2023-06-28 Morphic Holding, Inc. 28 Jun 2023 5 $0 4 Director 30 Jun 2023, 19:12
SRRK Scholar Rock Holding Corp 21 Jun 2023 1 $0 4 Director 22 Jun 2023, 19:20
/report/000120919123034039-nashat-amir-2023-06-01 Morphic Holding, Inc. 01 Jun 2023 1 $0 4 Director 02 Jun 2023, 19:04
SRRK Scholar Rock Holding Corp 22 Jun 2022 4 +$7,337,701 4 Director 24 Jun 2022, 16:27
/report/000120919122036116-nashat-amir-2022-06-08 Morphic Holding, Inc. 08 Jun 2022 1 $0 4 Director 10 Jun 2022, 19:00
SYRS Syros Pharmaceuticals, Inc. 01 Jun 2022 1 $0 4 Director 02 Jun 2022, 19:08
SRRK Scholar Rock Holding Corp 26 May 2022 1 $0 4 Director 27 May 2022, 16:34
/report/000120919122048888-nashat-amir-2022-05-18 Metacrine, Inc. 18 May 2022 1 $0 4 Director, 10%+ Owner 06 Sep 2022, 19:27
SRRK Scholar Rock Holding Corp 17 Nov 2021 9 $0 4 Director 19 Nov 2021, 15:32
/report/000120919122026240-nashat-amir-2021-06-16-restatement Morphic Holding, Inc. 16 Jun 2021 1 $0 4/A Director 29 Apr 2022, 16:17
SYRS Syros Pharmaceuticals, Inc. 08 Jun 2021 1 $0 4 Director 10 Jun 2021, 17:29
SRRK Scholar Rock Holding Corp 27 May 2021 1 $0 4 Director 01 Jun 2021, 16:11
/report/000120919121035786-nashat-amir-2021-05-24 Metacrine, Inc. 24 May 2021 1 $0 4 Director, 10%+ Owner 25 May 2021, 19:03
/report/000089924321020599-nashat-amir-2021-05-21 Morphic Holding, Inc. 21 May 2021 2 -$10,569,422 4 Director 25 May 2021, 19:20